More than 100 countries and international organisations have granted market approval or emergency use for Chinese COVID-19 vaccines
More than 30 Heads of State and Government were vaccinated with Chinese COVID-19 vaccines.
More than one billion doses of Chinese COVID-19 vaccines have been administered abroad, including over 180 million doses in Latin America and Caribbean.
Nearly 2.45 billion doses of Chinese COVID-19 vaccines have been administered on Chinese mainland.
Sinopharm COVID-19 vaccine and Sinovac COVID-19 vaccine are recognised by many countries for travel, including the United States and the United Kingdom.
Chinese COVID-19 vaccines adopt the technology of inactivated virus, which is the traditional technology for making vaccines and has been proven safe for decades.
WHO listed the Sinopharm COVID-19 vaccine and Sinovac COVID-19 vaccine for emergency use in May 2021 and June 2021 respectively, giving the green light for them to be rolled out globally.
WHO recommends the Sinopharm COVID-19 vaccine for adults 18 years and older, in a two-dose schedule with a spacing of three to four weeks.
Comments